Search results
Quanticate and PhaseV partner on new adaptive clinical trial service
FierceBiotech· 2 days agoIn a press release issued April 25, the companies said they would bring Quanticate’s statistical...
PhaseV and Quanticate Partner to Enable Clinical Trial Sponsors to Improve Recruitment, Time to...
FOX 8 Cleveland· 7 days agoPhaseV, a pioneer in software and machine learning (ML) for adaptive clinical trial optimization,...
PhaseV and Quanticate partner to help sponsors run more adaptive trials
Clinical Trials Arena via Yahoo Finance· 6 days agoPhaseV has partnered with contract research organization (CRO) Quanticate to improve the speed and...
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma -...
Benzinga· 2 days agoNEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ:INAB), a clinical-stage biopharmaceutical company advancing innovative gamma-delta T cell therapies, announced today that the first patient in its Phase
The future of oncology therapies: Stingray Therapeutics’ immune-boosting breakthrough
Digital Journal· 2 days agoCurrent immune oncology treatments face a critical limitation: they are only effective in about half...
Q1 2024 Chimerix Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 hours agoll maximize their response to October sixth at or prior to this duration of exposure was dose escalation studies are inherently adaptive with variable timelines. We remain ...
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Benzinga via Yahoo Finance· 7 days agoLimited (NASDAQ: VRAX) announced it is launching ‘ImmuneSelect' within the ViraxImmune T-Cell...
Does 'Brain Training' Really Improve Cognition?
Medscape· 3 days agoDoes 'Brain Training' Really Improve Cognition and Forestall Cognitive Decline? One popular approach is "brain training." While not a scientific term...
‘ChatGPT for CRISPR’ creates new gene-editing tools
Nature· 3 days agoSome of the AI-designed gene editors could be more versatile than those found in nature.
Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology...
Morningstar· 7 days agoSAN DIEGO and CALGARY, AB, April 25, 2024 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy ...
